Skip to content
PubReading [157] - Cell-SELEX Technology - S. Ohuchi episode artwork

Jun 30, 2022 29 min

PubReading [157] - Cell-SELEX Technology - S. Ohuchi

from PubReading

Aptamers are molecules identified from large combinatorial nucleic acid libraries by their high affinity to target molecules. Due to a variety of desired properties, aptamers are attractive alternatives to antibodies in molecular biology and medical applications. Aptamers are identified through an iterative selection–amplification process known as systematic evolution of ligands by exponential enrichment (SELEX). Although SELEX is typically carried out using purified target molecules, whole live cells are also employable as selection targets. This technology, Cell-SELEX, has several advantages. For example, generated aptamers are functional with a native conformation of the target molecule on live cells, and thus, cell surface transmembrane proteins would be targets even went their purifications in native conformations are difficult. In addition, cell-specific aptamers can be obtained without any knowledge about cell surface molecules on the target cells. Here, I review the progress of Cell-SELEX technology and discuss advantages of the technology DOI: 10.1089/biores.2012.0253265 - 2012

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

PubReading [157] - Cell-SELEX Technology - S. Ohuchi

0:00 29:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of PubReading?

This episode is 29 minutes long.

When was this PubReading episode published?

This episode was published on June 30, 2022.

Can I download this PubReading episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.